Global public health · 2026
'When you hear such rumours, you get scared': A comparison of vaccine-related concerns between the oral polio vaccine and Covid-19 vaccines among communities in Cameroon and Ethiopia.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lorenzetti Lara, Namey Emily, Corkum Melissa, Tsegaye Ademe, Lihemo Gloria, Mbang Massom Douglas, Risal Pokharel Deepa, McLain Grace, Mcintosh Ross
Аннотация
Despite widespread acceptance of the oral polio vaccine (OPV), vaccine hesitancy towards OPV in some countries presents a barrier to global eradication efforts. Between 2021 and 2022, the Global Polio Eradication Initiative implemented OPV campaigns concurrently with the roll-out of Covid-19 vaccines, for which vaccine hesitancy is well-documented. We sought to understand stakeholder perceptions of OPV and Covid-19 vaccines in Cameroon and Ethiopia. We implemented 32 focus group discussions (16 per country) with n = 216 caregivers of children under 5 and polio frontline workers to understand reasons for hesitancy, which included: fear of side effects, fear of vaccine overdosing, religious leaders being against vaccines and a lack of confidence in health workers, among others. These concerns were especially prominent toward the introduction of Covid-19 vaccines, less so toward OPV. Hesitancy reasons were more often reported as a concern held by community members, rather than participants themselves. Despite concerns, 69% of Ethiopian and 57% of Cameroonian respondents had received a Covid-19 vaccine. Our findings suggest a need for continued efforts to listen to caregiver and health worker concerns and co-create local solutions to enhance vaccine acceptability. Building trust amongst populations and addressing commonly held misconceptions is integral to vaccine introduction plans.